Leap Therapeutics is developing novel cancer drugs

DKN-01 Vial small.PNG


Our monoclonal antibodies are designed to target key cellular pathways that enable cancer to grow and proliferate, known as cancer cell signaling, and pathways that help the body’s immune system to identify and treat cancer.


Therapies targeting cancer cell signaling and T cells  offer new options for patients with cancer.  We are committed to making a difference in the lives of cancer patients. 

TRX molecule.PNG

Leap is developing drugs to change the practice of cancer medicine

LeapTherapeutics Logo_080718_FullColor-H

47 Thorndike Street, Suite B1-1
Cambridge, MA 
02141 USA
Phone: +1-617-714-0360

If you are interested in business development, e-mail us at bd@leaptx.com


Thank you for your interest in Leap Therapeutics. We will contact you shortly.